Filtering by:
Cervical CancerHPV Vaccination Rates Low Among Childhood Cancer Survivors
Despite the fact that the HPV vaccine is widely available and can help prevent forms of cancer caused by the virus, most young cancer survivors don’t get vaccinated.
FDA Approves a Biosimilar to Avastin for Cancer Treatment
The US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab-awwb) as the first biosimilar drug for treating cancer. It works the same way as Avastin (bevacizumab).
HPV Vaccination Rates are Rising Among American Teens
The Centers for Disease Control and Prevention (CDC) is reporting that vaccination rates for human papilloma virus (HPV) are rising among teenagers in the US.
American Cancer Society: 2 HPV Shots Instead of 3 OK for Ages 9-14
The American Cancer Society is endorsing a recommendation from the Advisory Committee on Immunization Practices (ACIP) that says boys and girls who start receiving the human papilloma virus (HPV) vaccine between ages 9 and 14 can get 2 doses instead of 3.